103 filings
8-K
CCCC
C4 Therapeutics Inc
8 Mar 24
Departure of Directors or Certain Officers
4:10pm
8-K
CCCC
C4 Therapeutics Inc
4 Mar 24
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
7:05am
S-8
CCCC
C4 Therapeutics Inc
22 Feb 24
Registration of securities for employees
9:01am
10-K
2023 FY
CCCC
C4 Therapeutics Inc
Annual report
22 Feb 24
7:20am
8-K
CCCC
C4 Therapeutics Inc
22 Feb 24
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:15am
8-K
lx558lqwo61
11 Jan 24
Regulation FD Disclosure
7:05am
8-K
99dmhabsrr8o
9 Jan 24
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
4:06pm
8-K
5wf255
12 Dec 23
Regulation FD Disclosure
4:28pm
8-K
er0 zkkyrpg
12 Dec 23
Entry into a Material Definitive Agreement
7:15am
8-K
5khr26 9wun
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
ainu3 a778ynwd8m
1 Nov 23
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
7:18am
8-K
ptyd3t726gk8km3nk1
5 Sep 23
C4 Therapeutics Announces Chief Financial Officer Succession
4:02pm
8-K
q8h7wwzu079tuhv1ru
8 Aug 23
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
7:09am
8-K
vuszwbanhypr
20 Jun 23
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
7:11am
8-K
7oy1ek8
30 May 23
Entry into a Material Definitive Agreement
7:30am
8-K
1522qu1w op
4 May 23
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
7:34am
EFFECT
op5nhgry
4 May 23
Notice of effectiveness
12:15am